Skip to content
10-Q

Quarterly Report

NEXEON MEDSYSTEMS INC

0001213900-18-006628

← back to feed
Filed
May 21, 2018 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2018 · May 21, 2018 27.72M sh
Capex Q1 2018 · Mar 31, 2018 $35.57K
Capex Q1 2018 · Mar 31, 2017 $5.22K
Operating Cash Flow Q1 2018 · Mar 31, 2018 −$683.91K
Operating Cash Flow Q1 2018 · Mar 31, 2017 −$1.26M
Short Term Debt Q1 2018 · Mar 31, 2018 $1.46M
Short Term Debt Q1 2018 · Dec 31, 2017 $866.48K
Cash And Equivalents Q1 2018 · Mar 31, 2018 $347.48K
Cash And Equivalents Q1 2018 · Dec 31, 2017 $883.96K
Cash And Equivalents restated Q1 2018 · Mar 31, 2017 $745.63K
Cash And Equivalents restated Q1 2018 · Dec 31, 2016 $2.12M
Stockholders Equity Q1 2018 · Mar 31, 2018 $11.17M
Stockholders Equity Q1 2018 · Dec 31, 2017 $11.87M
Current Liabilities Q1 2018 · Mar 31, 2018 $5.42M
Current Liabilities Q1 2018 · Dec 31, 2017 $5.13M
Total Liabilities Q1 2018 · Mar 31, 2018 $8.38M
Total Liabilities Q1 2018 · Dec 31, 2017 $8.48M
Current Assets Q1 2018 · Mar 31, 2018 $5.47M
Current Assets Q1 2018 · Dec 31, 2017 $5.93M
Total Assets Q1 2018 · Mar 31, 2018 $19.55M
Total Assets Q1 2018 · Dec 31, 2017 $20.35M
Sga Expense Q1 2018 · Mar 31, 2018 $957.18K
Sga Expense Q1 2018 · Mar 31, 2017 $670.36K
Rd Expense Q1 2018 · Mar 31, 2018 $519.26K
Rd Expense restated Q1 2018 · Mar 31, 2017 $681.85K
Net Income Q1 2018 · Mar 31, 2018 −$949.67K
Net Income restated Q1 2018 · Mar 31, 2017 −$1.68M
Operating Income Q1 2018 · Mar 31, 2018 −$800.14K
Operating Income restated Q1 2018 · Mar 31, 2017 −$1.64M
Gross Profit Q1 2018 · Mar 31, 2018 $1.04M
Gross Profit Q1 2018 · Mar 31, 2017 $9.04K
Cost Of Revenue Q1 2018 · Mar 31, 2018 $2.87M
Cost Of Revenue Q1 2018 · Mar 31, 2017 $9.04K
Revenue Q1 2018 · Mar 31, 2018 $2.87M
Revenue Q1 2018 · Mar 31, 2017 $9.04K